Non-diabetes status after diagnosis of impaired glucose tolerance and risk of long-term death and vascular complications: A post hoc analysis of the Da Qing Diabetes Prevention Outcome Study

医学 糖尿病 危险系数 析因分析 糖耐量受损 内科学 死因 入射(几何) 随机对照试验 置信区间 2型糖尿病 内分泌学 疾病 光学 物理
作者
Xin Qian,Jinping Wang,Qiuhong Gong,Yali An,Xinxing Feng,Siyao He,Xiaoping Chen,Wenjuan Wang,Lihong Zhang,Yuan-chi Hui,Xiuwei Zhai,Bo Zhang,Yanyan Chen,Guangwei Li
出处
期刊:PLOS Medicine [Public Library of Science]
卷期号:21 (7): e1004419-e1004419 被引量:5
标识
DOI:10.1371/journal.pmed.1004419
摘要

Background The association between years of non-diabetes status after diagnosis of impaired glucose tolerance (IGT) and the risk of long-term death and cardiovascular outcomes needed to be clarified. Methods and findings In this post hoc analysis, we included 540 individuals with IGT who participated in the original Da Qing Diabetes Prevention Study (DQDPS). In the DQDPS, all participants were diagnosed with IGT by a 75 g oral glucose tolerance test and randomized to intervention or control groups with a 6-year lifestyle intervention trial. After the completion of the trial, death, cardiovascular events, and microvascular complications were monitored over a 30-year follow-up. In this post hoc analysis, the Cox analysis assessed the extended risk of these outcomes in individuals who either remained non-diabetes status or progressed to diabetes at the end of 2, 4, and 6 years after diagnosis of IGT. In all participants, the difference in the cumulative incidence rate of the outcomes between the diabetes and non-diabetes group gradually increased over 30 years. Compared with the diabetes group, a significantly lower risk of all-cause death (hazard ratio [HR]: 0.74; 95% confidence interval [CI]: 0.57 to 0.97, p = 0.026), cardiovascular events (HR: 0.63; 95% CI: 0.49 to 0.82, p < 0.001), and microvascular complications (HR: 0.62; 95% CI: 0.45 to 0.86, p = 0.004) first emerged in individuals who remained non-diabetes at the 4 years visit, whereas the significant risk reduction in cardiovascular death was first observed at the end of 6 years (HR: 0.56; 95% CI: 0.39 to 0.81, p = 0.002) after adjustment for age, sex, smoking status, BMI, systolic blood pressure, blood glucose, total cholesterol, intervention, and medications (including insulin plus oral hypoglycaemics, antihypertensives, and lipid-lowering agents). The results in the original intervention group alone were similar to the whole group. The main limitations of our study are the limited number of participants and the sole ethnicity of the Chinese population. Conclusions In this study, we observed that maintaining several years of non-diabetes status after IGT diagnosis was associated with a significant reduction in long-term risk of death and vascular complications, and for most of these outcomes, maintaining at least 4 years of non-diabetes status may be needed to achieve a significant risk reduction.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
笨笨的雨真完成签到 ,获得积分10
1秒前
小脸儿想变大完成签到,获得积分20
1秒前
英俊的铭应助瑾瑜玉采纳,获得30
1秒前
小李爱吃大西瓜完成签到,获得积分10
1秒前
WENc发布了新的文献求助10
1秒前
ping发布了新的文献求助20
1秒前
爱笑的沛柔完成签到,获得积分10
1秒前
科研通AI6.4应助ooooodai采纳,获得10
1秒前
asdasd应助黎明深雪采纳,获得10
2秒前
冷静新烟发布了新的文献求助10
2秒前
深情安青应助dyfsj采纳,获得10
2秒前
2秒前
RUORUO发布了新的文献求助10
3秒前
3秒前
lzxucn完成签到,获得积分10
3秒前
dd完成签到,获得积分10
3秒前
luo完成签到 ,获得积分10
4秒前
Akim应助yuqinghui98采纳,获得10
4秒前
4秒前
舒适的傲柔完成签到,获得积分10
4秒前
6秒前
浅水鱼完成签到 ,获得积分10
7秒前
7秒前
515发布了新的文献求助10
8秒前
8秒前
8秒前
TR应助rtx00采纳,获得10
8秒前
8秒前
Ava应助迷路雨寒采纳,获得30
9秒前
9秒前
9秒前
9秒前
aaaa应助jesmina采纳,获得30
9秒前
10秒前
10秒前
10秒前
研友_5Y9Z75完成签到 ,获得积分0
10秒前
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Principles of town planning: translating concepts to applications 1000
2016 Venous Blood Study (VBS) (Final V3.0) 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
核安全综合知识2024版 500
Photothermal Science and Techniques 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7703441
求助须知:如何正确求助?哪些是违规求助? 9261824
关于积分的说明 20033481
捐赠科研通 7279022
什么是DOI,文献DOI怎么找? 3294555
关于科研通互助平台的介绍 2449847
邀请新用户注册赠送积分活动 2301336